Tests in bacteria, cells, and mice all came back negative, suggesting the compound does not pose carcinogenic risk through DNA damage mechanisms
This is not equivalent to the FDA granting approval as a therapeutic drug, and it carries no standing under UK or EU medicines law
Thats why were focusing today on AHK-Cu, a truly fascinating peptide with immense research potential
Every shopping path leads back to the same core standard: research-use positioning, third-party quality signals, transparent documentation, and careful handling guidance
10.1016/s0016-5085(12)60808-7 50 SchijnsW.HomanJ.van der MeerL.JanssenI
Not for Human Consumption.